文献速递心境障碍会诊联络精神医学

PsycheMERGE网络研究:抑郁多基因评分与白细胞计数的关联

Use of the PsycheMERGE Network to Investigate the Association Between Depression Polygenic Scores and White Blood Cell Count.
PubMed 文献 · JAMA Psychiatry · 2021-01-01

IMPORTANCE: Although depression is a common psychiatric disorder, its underlying biological basis remains poorly understood.…

要点

  • 抑郁多基因评分与白细胞计数呈稳健正关联,并在4个医疗系统荟萃分析中重复验证。
  • 中介分析提示关联为双向:白细胞计数解释抑郁多基因评分与抑郁诊断关联的2.5%,抑郁诊断解释其与白细胞计数关联的9.8%。
  • 孟德尔随机化支持白细胞升高增加抑郁风险,但抑郁作为暴露未见影响白细胞计数的证据。

核心结论

  • 抑郁多基因评分升高与白细胞计数升高相关,且该关联可能是双向的。
  • 免疫系统可能在抑郁病因学中具有潜在重要性,或有助于未来临床生物标志物和靶向治疗开发。

研究设计与样本

  • 在各医疗系统分别分析并荟萃分析,主要分析在范德堡大学医学中心生物样本库进行,并在另外3个PsycheMERGE站点重复验证。

主要发现

  • 实验室全关联扫描显示抑郁多基因评分与白细胞计数稳健关联(β=0.03;SE=0.004;P=1.07×10^-17)。
  • 4个医疗系统荟萃分析重复验证该关联(β=0.03;SE=0.002;P=1.03×10^-136)。
  • 中介分析提示双向关联:白细胞计数解释抑郁多基因评分与抑郁诊断关联的2.5%(95%CI 2.2%-20.8%;P=2.84×10^-70)。
  • 抑郁诊断解释抑郁多基因评分与白细胞计数关联的9.8%(95%CI 8.4%-11.1%;P=1.78×10^-44)。
  • 孟德尔随机化支持白细胞计数升高与抑郁风险增加相关,但抑郁作为暴露未见影响白细胞计数的证据。

临床怎么用

  • 临床可关注抑郁患者白细胞计数变化,作为潜在免疫相关生物标志物线索。
  • 未来可基于免疫机制探索抑郁的靶向治疗和生物标志物开发。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Although depression is a common psychiatric disorder, its underlying biological basis remains poorly understood. Pairing depression polygenic scores with the results of clinical laboratory tests can reveal biological processes involved in depression etiology and in the physiological changes resulting from depression. OBJECTIVE: To characterize the association between depression polygenic scores and an inflammatory biomarker, ie, white blood cell count. DESIGN, SETTING, AND PARTICIPANTS: This genetic association study was conducted from May 19, 2019, to June 5, 2021, using electronic health record data from 382 452 patients across 4 health care systems. Analyses were conducted separately in each health care system and meta-analyzed across all systems. Primary analyses were conducted in Vanderbilt University Medical Center's biobank. Replication analyses were conducted across 3 other PsycheMERGE sites: Icahn School of Medicine at Mount Sinai, Mass General Brigham, and the Million Veteran Program. All patients with available genetic data and recorded white blood cell count measurements were included in the analyses. Primary analyses were conducted in individuals of European descent and then repeated in a population of individuals of African descent. EXPOSURES: Depression polygenic scores. MAIN OUTCOMES AND MEASURES: White blood cell count. RESULTS: Across the 4 PsycheMERGE sites, there were 382 452 total participants of European ancestry (18.7% female; median age, 57.9 years) and 12 383 participants of African ancestry (61.1% female; median age, 39.0 [range, birth-90.0 years]). A laboratory-wide association scan revealed a robust association between depression polygenic scores and white blood cell count (β, 0.03; SE, 0.004; P = 1.07 × 10-17), which was replicated in a meta-analysis across the 4 health care systems (β, 0.03; SE, 0.002; P = 1.03 × 10-136). Mediation analyses suggested a bidirectional association, with white blood cell count accounting for 2.5% of the association of depression polygenic score with depression diagnosis (95% CI, 2.2%-20.8%; P = 2.84 × 10-70) and depression diagnosis accounting for 9.8% of the association of depression polygenic score with white blood cell count (95% CI, 8.4%-11.1%; P = 1.78 × 10-44). Mendelian randomization provided additional support for an association between increased white blood count and depression risk, but depression modeled as the exposure showed no evidence of an influence on white blood cell counts. CONCLUSIONS AND RELEVANCE: This genetic association study found that increased depression polygenic scores were associated with increased white blood cell count, and suggests that this association may be bidirectional. These findings highlight the potential importance of the immune system in the etiology of depression and may motivate future development of clinical biomarkers and targeted treatment options for depression.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Sealock JM, Lee YH, Moscati A, et al. Use of the PsycheMERGE Network to Investigate the Association Between Depression Polygenic Scores and White Blood Cell Count. JAMA Psychiatry. 2021. PMID: 34668925. doi:10.1001/jamapsychiatry.2021.2959

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。